Theralase Technologies leads the way in light-activated cancer therapies
Deep Dive - Theralase Technologies Inc
Source: proactiveinvestors.com
Complete Response News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Complete Response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Complete Response Today - Breaking & Trending Today
Further CYP-001 GvHD Clinical Data Published in Nature Medicine
/PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics,...
Source: prnewswire.com
Galapagos showcases innovative approach in hematological
Two oral presentations and one poster on encore preliminary data from Phase 1/2 CD19 CAR-T studies in non-Hodgkin lymphoma (NHL) and chronic lymphocytic...
Source: globenewswire.com
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (“ETBs”), to create novel therapies with potent differentiated mechanisms of action for cancer, today reported financial results for the fourth quarter and full year ended December 31, 2023. Company Highlights Durable s
Source: yahoo.com
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Strategic shift prioritizes the development of GLP-1 implants for the treatment of obesity and chronic weight management Positive NPM-115 preclinical weight loss data comparable to semaglutide,...
Source: marketscreener.com